나이벡

138610KOSDAQ의료용품 및 기타 의약 관련제품 제조업

44.3 / 100

Reference Date: 2026-06-10

Financial Score10.0 / 40

News Sentiment21.3 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: PER raises overvaluation concerns, PBR raises overvaluation concerns. Plunged 21.4% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Nabix operates in the fields of bio-regenerative materials, peptide pharmaceuticals, and oral health products, holding global certifications such as FDA, CE, and NMPA, and selling products worldwide. The company is focusing on expanding its global market through the commercialization of new products like PeptiCol EZgraft and obtaining European MDR certification, while also developing early diagnosis kits and treatments for periodontal diseases.

Number of Employees

93people

Average Salary

59.4M KRW

Score Calculation Basis

Detailed Financial Score

PER

44.90Industry Average 19.190.0Point

2.3x industry avg (risky)

PBR

4.63Industry Average 1.300.0Point

3.6x industry avg (risky)

ROE

11.89Industry Average -4.893.5Point

Well below industry avg

Debt Ratio

11.70Industry Average 6.860.5Point

1.7x industry avg (risky)

Trend 2023~20256.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲44.8% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲40.6% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -13.0% (improving, 3yr)

Detailed News Sentiment

5 totalPositive 5Neutral 0Negative 0Average Sentiment Score 85

Positive
나이벡, 브라질 품목허가 획득…중남미 치과 시장 진출 본격화
나이벡의 브라질 품목허가 획득으로 중남미 치과 시장 진출이 가속화되어 긍정적인 성장 전망이 기대된다.
Positive
나이벡, IPF 치료제 핵심 원천 특허 유럽 등록...글로벌 사업화 기...
나이벡의 IPF 치료제 핵심 특허 유럽 등록으로 글로벌 사업 확장 기대감 증가.
Positive
나이벡, 1Q 영업이익·순이익 흑자전환…"수익구조 개선 지속"
나이벡이 1분기 흑자전환을 달성하며 수익성 개선 추세를 이어갔다.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 18,680Won52-week high 52,30052-week low 18,680

1-month return0.0Point

1m -21.35% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral기업설명회(IR)개최2026-05-18
Neutral분기보고서 (2026.03)2026-05-14